178 related articles for article (PubMed ID: 20006307)
1. Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis.
Olaleye OA; Bishai WR; Liu JO
Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S55-9. PubMed ID: 20006307
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis.
John SF; Aniemeke E; Ha NP; Chong CR; Gu P; Zhou J; Zhang Y; Graviss EA; Liu JO; Olaleye OA
Tuberculosis (Edinb); 2016 Dec; 101S():S73-S77. PubMed ID: 27856197
[TBL] [Abstract][Full Text] [Related]
6. New tuberculosis drugs on the horizon.
Cole ST; Riccardi G
Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.
Almeida Da Silva PE; Palomino JC
J Antimicrob Chemother; 2011 Jul; 66(7):1417-30. PubMed ID: 21558086
[TBL] [Abstract][Full Text] [Related]
8. Guanosine triphosphatases as novel therapeutic targets in tuberculosis.
Rajni ; Meena LS
Int J Infect Dis; 2010 Aug; 14(8):e682-7. PubMed ID: 20207570
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv.
Lin X; Xu S; Yang Y; Wu J; Wang H; Shen H; Wang H
Protein Expr Purif; 2009 Mar; 64(1):8-15. PubMed ID: 18952181
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
[TBL] [Abstract][Full Text] [Related]
11. Novel drug target strategies against Mycobacterium tuberculosis.
Murphy DJ; Brown JR
Curr Opin Microbiol; 2008 Oct; 11(5):422-7. PubMed ID: 18801459
[TBL] [Abstract][Full Text] [Related]
12. New strategies in fighting TB: targeting Mycobacterium tuberculosis-secreted phosphatases MptpA & MptpB.
Silva AP; Tabernero L
Future Med Chem; 2010 Aug; 2(8):1325-37. PubMed ID: 21426021
[TBL] [Abstract][Full Text] [Related]
13. Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis.
Olaleye O; Raghunand TR; Bhat S; Chong C; Gu P; Zhou J; Zhang Y; Bishai WR; Liu JO
Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1(Suppl 1):S61-5. PubMed ID: 22115541
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
15. The significance of GlgE as a new target for tuberculosis.
Kalscheuer R; Jacobs WR
Drug News Perspect; 2010 Dec; 23(10):619-24. PubMed ID: 21180647
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis: drug resistance and future perspectives.
Riccardi G; Pasca MR; Buroni S
Future Microbiol; 2009 Jun; 4(5):597-614. PubMed ID: 19492969
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of drug resistance in tuberculosis.
Riska PF; Jacobs WR; Alland D
Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S4-10. PubMed ID: 10688142
[TBL] [Abstract][Full Text] [Related]
18. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
19. Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery.
Khedkar SA; Malde AK; Coutinho EC
J Mol Graph Model; 2005 Jan; 23(4):355-66. PubMed ID: 15670956
[TBL] [Abstract][Full Text] [Related]
20. Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets.
Roberts DM; Personne Y; Ollinger J; Parish T
Future Microbiol; 2013 May; 8(5):621-31. PubMed ID: 23642117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
